Cargando…

Biomarkers, Clinical Variables, and the CHA(2)DS(2)-VASc Score to Detect Silent Brain Infarcts in Atrial Fibrillation Patients

Detalles Bibliográficos
Autores principales:	Krisai, Philipp, Eken, Ceylan, Aeschbacher, Stefanie, Coslovsky, Michael, Rolny, Vinzent, Carmine, Desirée, Gauthier, Lorenzo Grazioli, Beer, Jürg, Roten, Laurent, Baretella, Oliver, Rodondi, Nicolas, Bonati, Leo H., Zuern, Christine S., Müller, Christian, Conen, David, Kühne, Michael, Osswald, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Stroke Society 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521248/ https://www.ncbi.nlm.nih.gov/pubmed/34649390 http://dx.doi.org/10.5853/jos.2021.02068

Ejemplares similares

Association of the CHA(2)D(S(2))-VASc Score and Its Components With Overt and Silent Ischemic Brain Lesions in Patients With Atrial Fibrillation
por: Steiner, Fabienne, et al.
Publicado: (2021)

Silent brain infarcts impact on cognitive function in atrial fibrillation
por: Kühne, Michael, et al.
Publicado: (2022)

Association of Heart Rate Variability With Silent Brain Infarcts in Patients With Atrial Fibrillation
por: Hämmerle, Peter, et al.
Publicado: (2021)

Cardiac autonomic function and cognitive performance in patients with atrial fibrillation
por: Hämmerle, Peter, et al.
Publicado: (2021)

Blood Pressure and Brain Lesions in Patients With Atrial Fibrillation
por: Aeschbacher, Stefanie, et al.
Publicado: (2020)

Neurocognitive function in patients with atrial fibrillation undergoing pulmonary vein isolation
por: Zwimpfer, Leon, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

Association of Diabetes With Atrial Fibrillation Phenotype and Cardiac and Neurological Comorbidities: Insights From the Swiss‐AF Study
por: Bano, Arjola, et al.
Publicado: (2021)

Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillation
por: Reddiess, Philipp, et al.
Publicado: (2021)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

Silent cerebral infarcts in patients with atrial fibrillation: Clinical implications of an imaging-adjusted CHA(2)DS(2)-VASc score
por: Bretzman, John P., et al.
Publicado: (2022)

Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation
por: Girod, Marc, et al.
Publicado: (2022)

CHA(2)DS(2)-Vasc score and CHA(2)DS(2)-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
por: Zhao, Sheng Gang, et al.
Publicado: (2019)

CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients
por: Gunduz, Ramazan, et al.
Publicado: (2021)

Heart Rate Variability Triangular Index as a Predictor of Cardiovascular Mortality in Patients With Atrial Fibrillation
por: Hämmerle, Peter, et al.
Publicado: (2020)

Bone Morphogenetic Protein 10—A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation
por: Hennings, Elisa, et al.
Publicado: (2023)

Sex differences of vascular brain lesions in patients with atrial fibrillation
por: Ceylan, Selinda, et al.
Publicado: (2022)

Heart failure: a weak link in CHA(2)DS(2)‐VASc
por: Friberg, Leif, et al.
Publicado: (2018)

CHA(2)DS(2)-VASc Score in Cardio-Oncology: Sharpening the Rules
por: López-Fernández, Teresa
Publicado: (2023)

Predictive value of CHA(2)DS(2)-VASc and CHA(2)DS(2)-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction
por: Kilic, Salih, et al.
Publicado: (2019)

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

Cheating the CHA(2)DS(2)-VASc Score: Thromboembolism in Apical Hypertrophic Cardiomyopathy
por: Weir, Robin A. P., et al.
Publicado: (2014)

Correlation between CHA(2)DS(2)-VASc Score and Glaucoma Treatment and Prognosis
por: Pikkel, Yoav Y., et al.
Publicado: (2018)

Beyond CHA(2)DS(2)-VASc in atrial fibrillation: the atrium and the risk of stroke
por: Boccanelli, Alessandro
Publicado: (2020)

Escore CHA2DS2-VASc: O Que Mais Podemos Predizer?
por: Maia, Adnaldo da Silveira
Publicado: (2023)

Bone morphogenetic protein 10 as a predictor for recurrent atrial fibrillation after catheter ablation
por: Hennings, E, et al.
Publicado: (2023)

The Omega-3 Fatty Acid Eicosapentaenoic Acid (EPA) Correlates Inversely with Ischemic Brain Infarcts in Patients with Atrial Fibrillation
por: Reiner, Martin F., et al.
Publicado: (2021)

Value of the CHA(2)DS(2)‐VASc score for predicting outcome in patients with heart failure
por: Shuvy, Mony, et al.
Publicado: (2020)

Coronary Embolism despite CHA₂DS₂-VASc Score of Zero: Should We Reconsider Anticoagulation?
por: Ahmed, Ammar, et al.
Publicado: (2021)

Does CHA2DS2-VASc score predict mortality in chronic kidney disease?
por: Goudis, Christos, et al.
Publicado: (2021)

Stroke and systemic embolism risk in patients with CHA(2)DS(2)‐VASc score of 0
por: Babayiğit, Erdi, et al.
Publicado: (2023)

Prognostic Impacts of CHADS(2), CHA(2)DS(2)-VASc, and CHA(2)DS(2)-VASc-HS Scores on Clinical Outcomes After Elective Drug-Eluting Stent Placement for De Novo Coronary Stenosis
por: Ukaji, Tomoaki, et al.
Publicado: (2023)

Association of bone morphogenetic protein 10 and recurrent atrial fibrillation after catheter ablation
por: Hennings, Elisa, et al.
Publicado: (2023)

High CHA(2)DS(2)-VASc score without atrial fibrillation: ‘NAO yes, NAO no’
por: Perna, Gian Piero
Publicado: (2019)

What should the C (‘congestive heart failure’) represent in the CHA(2)DS(2)‐VASc score?
por: Mulder, Bart A., et al.
Publicado: (2020)

CHA(2)DS(2)‐VASc Score and the Risk of Ventricular Tachyarrhythmic Events and Mortality in MADIT‐CRT
por: Nof, Eyal, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc score stratifies mortality risk in patients with and without atrial fibrillation
por: Harb, Serge C, et al.
Publicado: (2021)

Predictive Value of CHA(2)DS(2) -VASc-HSF Score for Severity of Acute Coronary Syndrome
por: Liu, Jingyi, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc score for in-hospital recurrence risk stratification in patients with myocardial infarction
por: Pang, Hui, et al.
Publicado: (2022)

Assessment of the atrial fibrillation burden in Holter ECG recordings using artificial intelligence
por: Hennings, E, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_65lngpbq4hpeaseotus6gpsgj6